The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5 - Centre de Recherche en Cancérologie de Marseille Accéder directement au contenu
Article Dans Une Revue Blood Advances Année : 2021

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5

Résumé

Tissue invasion by tumor cells induces a host inflammatory response that variably impacts tumorigenesis. This has been well documented for tumor-associated macrophages (TAMs) that could play a pro/M2- or an anti/M1-tumoral function. TAMs frequently infiltrate diffuse large B-cell lymphoma (DLBCL), an aggressive neoplasm arising from germinal center–experienced B cells. However, the pathway leading to the presence of TAMs in DLBCL remains unknown, and their impact is unclear. Here, we show that some DLBCL tumor cells expressed the chemokine CCL5, enabling the differential recruitment of blood monocytes through their expression of CCR1 and CCR5. CCL5 expression by DLBCL was not related to molecular subtypes, and healthy tonsillar B cells did not produce this chemokine, implying a posttransformation event. A single-cell analysis revealed that most DLBCL TAMs had a noncanonical gene signature with the concomitant expression of M1 and M2 genes. The presence of noncanonical TAMs may explain the lack of impact of macrophages on DLBCL development reported in some survival studies.
Fichier principal
Vignette du fichier
advancesADV2021004203.pdf (2 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04444537 , version 1 (14-05-2024)

Identifiants

Citer

Benoît Manfroi, Maria de Grandis, Jérôme Moreaux, Sébastien Tabruyn, Jean-François Mayol, et al.. The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5. Blood Advances, 2021, 5 (21), pp.4338-4351. ⟨10.1182/bloodadvances.2021004203⟩. ⟨hal-04444537⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More